Cases 11 - 20 of 313
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc.
as 1:2022cv00023
Counter Defendant:
Novo Nordisk, Inc. and Novo Nordisk, A/S
Defendant:
Mylan Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pfizer Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2021cv00839
Counter Defendant:
Warner-Lambert Company LLC, Pfizer Inc and PF Prism IMB B.V.
Counter Claimant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2020cv00244
Plaintiff:
Pfizer Inc., Warner-Lambert Company LLC and PF Prism IMB B.V.
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2020cv00090
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2020cv00019
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited
Cause Of Action: 35 U.S.C. § 271
Takeda Pharmaceuticals U.S.A., Inc. v. Mylan Pharmaceuticals Inc.
as 1:2019cv02216
Defendant:
Mylan Pharmaceuticals Inc.
Plaintiff:
Takeda Pharmaceuticals U.S.A., Inc.
3Rd Party Defendant:
Hikma Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.
Intervenor:
Par Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Mylan Pharmaceuticals Inc.
as 1:2019cv01863
Plaintiff:
Warner-Lambert Company LLC, PF Prism C.V., Pfizer Manufacturing Holdings LLC and others
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
UCB, Inc. et al v. Mylan Technologies, Inc. et al
as 2:2019cv00148
Plaintiff:
UCB, Inc., LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH and others
Defendant:
Mylan Pharmaceuticals, Inc., Mylan Technologies, Inc. and Mylan, Inc.
Counter Claimant:
Mylan Technologies Inc.
Cause Of Action: 35 U.S.C. § 271
Merck Sharp & Dohme Corp. v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv01489
Defendant:
Mylan Pharmaceuticals Inc.
Plaintiff:
Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals, Inc.
as 1:2019cv01118
Defendant:
Mylan Pharmaceuticals, Inc.
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 28 U.S.C. § 2201
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
